BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharma Journalist
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20210101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20221011
DTEND;VALUE=DATE:20221014
DTSTAMP:20260516T041142
CREATED:20220617T103229Z
LAST-MODIFIED:20220617T103229Z
UID:34419-1665446400-1665705599@www.pharmajournalist.com
SUMMARY:Reuters Events: Pharma 2022
DESCRIPTION:Comprehensive frameworks for equitable access and accelerated digital transformations are soon to be realized. But progress is slowing\, risking a return to the old model plagued by persistent health disparities. \nTo thrive\, each strategy and tactic must be centred with a whole-human approach\, ensuring an agile\, patient-driven\, technology-enabled change. \nYou must advance intelligent automation\, delivering value-driven content that enhance patient and HCP experiences\, activate new skillsets for field teams to strengthen clinical practices\, whilst collaborating with stakeholders – and competitors – to drastically improve equitable access to the vast galaxy of innovation improving patient outcomes and propelling commercial growth. \nReuters Events: Pharma 2022 (11-13 October\, Nice France – formerly eyeforpharma Barcelona) is the only place where patient experts\, leading solution providers\, and pharma changemakers – from commercial\, marketing\, medical affairs\, patient engagement\, market access and RWE – commit to business transformation as the catalyst for maximum patient impact. \nTo know more visit: https://bit.ly/3xVKqN8
URL:https://www.pharmajournalist.com/event/reuters-events-pharma-2022/
LOCATION:Nice Acropolis Convention Center\, Nice\, France
ORGANIZER;CN="Reuters Events":MAILTO:Matt.atkinson@thomsonreuters.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20221011
DTEND;VALUE=DATE:20221014
DTSTAMP:20260516T041142
CREATED:20220630T100728Z
LAST-MODIFIED:20220630T100728Z
UID:34561-1665446400-1665705599@www.pharmajournalist.com
SUMMARY:10th IMPACCT Real World Evidence Summit
DESCRIPTION:Returning in person for its 10th year anniversary\, the IMPACCT: Real World Evidence Summit will deep dive into the use of RWE for regulatory submissions and improved clinical trial design to help you navigate the regulatory landscape. \nFollowing recent FDA and EMA guidelines\, this comprehensive industry-led forum will address how drug developers can leverage RWE from beginning to end of study\, ensure clinical studies are well-designed\, include appropriate protections for their patients and upload data integrity. \nJoin 100+ senior leaders in RWE\, RWD\, real world analytics experts & epidemiologists from pharma and biotech to take part in this three day summit with over 18 hours of exclusive content. \nTo know more visit: https://ter.li/tymfzh
URL:https://www.pharmajournalist.com/event/10th-impacct-real-world-evidence-summit/
LOCATION:Crowne Plaza Woburn\, 15 Middlesex Canal Park Rd\, Woburn\, MA\, 01801\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20221011
DTEND;VALUE=DATE:20221014
DTSTAMP:20260516T041142
CREATED:20220712T103251Z
LAST-MODIFIED:20220713T075908Z
UID:34648-1665446400-1665705599@www.pharmajournalist.com
SUMMARY:3rd Commercializing Flow Chemistry Summit 2022
DESCRIPTION:With the exciting proof-of-concept milestones from Phlow\, commitments from global regulatory agencies\, and breakthroughs from the likes of AbbVie\, AstraZeneca\, Merck and BMS\, over the last 12 months flow chemistry continues to take off at an exponential rate\, further evidenced by the significant investments from CDMOs such as Almac\, Corden Pharma\, Sterling and Cambrex. \nShowcasing the steep progress being made whilst addressing the field’s most front-of-mind challenges to enable the full potential of continuous chemistry to come to fruition\, the 3rd Annual Commercializing Flow Chemistry Summit is back to bridge the gap between academic and industry innovation as your only meeting bringing both technical and strategic flow chemistry intelligence under one roof in Boston this October. \nUniting 100+ Process Development\, Chemistry & Control\, PAT\, CMC\, Continuous Manufacturing and Engineering experts across biopharma\, academia\, CDMO and fine chemical & API organizations for the first time in person\, this is your prime opportunity to turn flow chemistry into industrial applications and implement advanced process control strategies to ensure product quality and meet regulatory expectations. \nFor practical takeaways across technical chemical engineering\, process development\, batch to flow transitions\, novel chemistries\, scale-up\, PAT implementation & more\, reduce your development cycle and enhance operational efficiency by attending the 3rd CFC Summit 2022! \nTo know more visit: https://ter.li/pqcevv
URL:https://www.pharmajournalist.com/event/3rd-commercializing-flow-chemistry-summit-2022/
LOCATION:The Bostonian\, 26 North St\, Boston\, MA\, 02109\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR